Rockefeller Capital Management L.P. Sorrento Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.33 $2,480 - $4,660	-2,000 Reduced 36.36%	3,500 $7,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $9,300 - $14,460	-2,000 Reduced 26.67%	5,500 $25,000
Q2 2021 Aug 10, 2021	SELL	$6.35 - $10.0 $7,620 - $12,000	-1,200 Reduced 13.79%	7,500 $72,000
Q1 2021 May 11, 2021	BUY	$7.03 - $16.51 $3,866 - $9,080	550 Added 6.75%	8,700 $71,000
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $19,296 - $40,032	3,350 Added 69.79%	8,150 $55,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $9,255 - $28,230	1,500 Added 45.45%	4,800 $53,000
Q2 2020 Aug 12, 2020	BUY	$1.73 - $6.76 $1,730 - $6,760	1,000 Added 43.48%	3,300 $21,000
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.69 $4,715 - $6,187	2,300 New	2,300 $5,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.